Skip to content
OpenCapital
Get started

Lyell Immunopharma, Inc. LYEL Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$2.0KMiss by $1.0K
EPS-$1.10Beat by $1.68
Revenue estimate$3.0K
EPS estimate-$2.78

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$4.6K
EPS estimate-$2.02

Versus estimates

Revenue

Q1 2026$2.0KMiss by $1.0K
Q4 2025$6.0KMiss by $9.3KQ3 2025$15.0KQ2 2025$8.0KBeat by $4.0KQ1 2025$7.0KQ4 2024$11.0K

Diluted EPS

Q1 2026-$1.10Beat by $1.68
Q4 2025-$7.68Miss by $5.53Q3 2025-$2.13Beat by $0.68Q2 2025-$2.89Beat by $0.91Q1 2025-$3.60Beat by $0.20Q4 2024-$0.72Miss by $0.54

Ask the moment Lyell Immunopharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lyell Immunopharma, Inc. report Q1 2026 earnings?
Lyell Immunopharma, Inc. (LYEL) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Lyell Immunopharma, Inc.'s Q1 2026 revenue and EPS?
Lyell Immunopharma, Inc. reported revenue of $2.0K and eps of $-1.10 for Q1 2026.
Did Lyell Immunopharma, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $3.0K by $1.0K. EPS beat the consensus estimate of $-2.78 by $1.68.
How did Lyell Immunopharma, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 71.4% from $7.0K a year earlier and eps grew 69.4% from $-3.60.
Where can I find Lyell Immunopharma, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031269) and the 10-Q periodic report (0001628280-26-031284) directly on SEC EDGAR. The filing index links above go to sec.gov.